Director, Payer Access Cell Therapy

The role

This person will formulate and execute strategic account plans by engaging regional and national payors and targeted health systems. They will ensure positive payor medical policies, reimbursement preparation, and support for Amtagvi products.

What you will do

• Engage regional and national payors to support product value proposition, coverage, coding, and reimbursement.
• Develop business champions in targeted hospitals, health systems, and large group practices.
• Ensure payer policies align with label, NCCN Guidelines, and clinical trial criteria.
• Prepare the payer marketplace for future product indications with updated clinical data.
• Pull through with providers and payers on identified clinical needs.
• Partner with hospitals and health systems to plan for financial process needs.
• Manage C-Suite relationships through FDAMA 114 at provider accounts.
• Collaborate with IovanceCares Case Management and Field Sales to resolve access issues.
• Track key metrics to ensure accuracy of executive dashboards.
• Present analysis of scientific data, clinical practice goals, and economic outcomes.

Required qualifications

• 12+ years of related payor or hospital reimbursement account experience in the healthcare industry.
• Proven relationships with Commercial Payor Medical Directors, Medicare Advantage plans, Medicare MACs, FFS State Medicaid, and Managed Medicaid stakeholders.
• Strong analytical skills with experience in payor CRM, payor policy development, and using data tracking tools.
• Problem solving skills and multi-tasking experience.
• Proactive, results-oriented, collaborative, self-starter with demonstrated strong leadership skills.
• Excellent presentation skills, both written and verbal.
• Knowledge of regulations and laws governing patient identifying information, OIG, FDA, and CMS policies.
• High level of proficiency in Microsoft Excel, Word and Power Point.
• Bachelor’s Degree

Nice to have

• Inpatient hospital pull through experience
• Experience in cell or gene therapy products
• Master’s Degree

About the company

Iovance Biotherapeutics, Inc. is the global leader in innovating, developing, and delivering tumor infiltrating lymphocyte (TIL) cell therapies for patients with solid tumors. The company operates as an end-to-end cell therapy company with centralized U.S.-based manufacturing.